145 related articles for article (PubMed ID: 16038189)
1. Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography-tandem mass spectrometry.
Gjerde J; Kisanga ER; Hauglid M; Holm PI; Mellgren G; Lien EA
J Chromatogr A; 2005 Jul; 1082(1):6-14. PubMed ID: 16038189
[TBL] [Abstract][Full Text] [Related]
2. Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide.
Gjerde J; Gandini S; Guerrieri-Gonzaga A; Haugan Moi LL; Aristarco V; Mellgren G; Decensi A; Lien EA
Breast Cancer Res Treat; 2012 Jul; 134(2):693-700. PubMed ID: 22562123
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry.
Teunissen SF; Jager NG; Rosing H; Schinkel AH; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1677-85. PubMed ID: 21543272
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment.
Lien EA; Søiland H; Lundgren S; Aas T; Steen VM; Mellgren G; Gjerde J
Breast Cancer Res Treat; 2013 Sep; 141(2):243-8. PubMed ID: 23996142
[TBL] [Abstract][Full Text] [Related]
5. An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients.
Dahmane E; Mercier T; Zanolari B; Cruchon S; Guignard N; Buclin T; Leyvraz S; Zaman K; Csajka C; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3402-14. PubMed ID: 21094101
[TBL] [Abstract][Full Text] [Related]
6. Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism.
Gjerde J; Hauglid M; Breilid H; Lundgren S; Varhaug JE; Kisanga ER; Mellgren G; Steen VM; Lien EA
Ann Oncol; 2008 Jan; 19(1):56-61. PubMed ID: 17947222
[TBL] [Abstract][Full Text] [Related]
7. Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry.
Binkhorst L; Mathijssen RH; Ghobadi Moghaddam-Helmantel IM; de Bruijn P; van Gelder T; Wiemer EA; Loos WJ
J Pharm Biomed Anal; 2011 Dec; 56(5):1016-23. PubMed ID: 21872414
[TBL] [Abstract][Full Text] [Related]
8. The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells.
Helland T; Gjerde J; Dankel S; Fenne IS; Skartveit L; Drangevåg A; Bozickovic O; Flågeng MH; Søiland H; Mellgren G; Lien EA
PLoS One; 2015; 10(4):e0122339. PubMed ID: 25867603
[TBL] [Abstract][Full Text] [Related]
9. Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots--development, validation and clinical application during breast cancer adjuvant therapy.
Antunes MV; Raymundo S; de Oliveira V; Staudt DE; Gössling G; Peteffi GP; Biazús JV; Cavalheiro JA; Tre-Hardy M; Capron A; Haufroid V; Wallemacq P; Schwartsmann G; Linden R
Talanta; 2015 Jan; 132():775-84. PubMed ID: 25476377
[TBL] [Abstract][Full Text] [Related]
10. Liquid chromatography-mass spectrometry method for the quantification of tamoxifen and its metabolite 4-hydroxytamoxifen in rat plasma: application to interaction study with biochanin A (an isoflavone).
Singh SP; Wahajuddin ; Ali MM; Kohli K; Jain GK
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct; 879(27):2845-51. PubMed ID: 21890435
[TBL] [Abstract][Full Text] [Related]
11. Determination of tamoxifen and four metabolites in serum by low-dispersion liquid chromatography.
Lien EA; Ueland PM; Solheim E; Kvinnsland S
Clin Chem; 1987 Sep; 33(9):1608-14. PubMed ID: 3621560
[TBL] [Abstract][Full Text] [Related]
12. Fast method for simultaneous quantification of tamoxifen and metabolites in dried blood spots using an entry level LC-MS/MS system.
Tré-Hardy M; Capron A; Antunes MV; Linden R; Wallemacq P
Clin Biochem; 2016 Nov; 49(16-17):1295-1298. PubMed ID: 27498307
[TBL] [Abstract][Full Text] [Related]
13. Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer.
Gjerde J; Geisler J; Lundgren S; Ekse D; Varhaug JE; Mellgren G; Steen VM; Lien EA
BMC Cancer; 2010 Jun; 10():313. PubMed ID: 20565970
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry.
Teunissen SF; Rosing H; Koornstra RH; Linn SC; Schellens JH; Schinkel AH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2519-29. PubMed ID: 19589736
[TBL] [Abstract][Full Text] [Related]
15. Determination of tamoxifen and its main metabolites in plasma samples from breast cancer patients by micellar liquid chromatography.
Peris-Vicente J; Ochoa-Aranda E; Bose D; Esteve-Romero J
Talanta; 2015 Jan; 131():535-40. PubMed ID: 25281137
[TBL] [Abstract][Full Text] [Related]
16. Quantification of tamoxifen and metabolites and soy isoflavones in human plasma using liquid chromatography with electrospray ionization tandem mass spectrometry.
Williams LD; Twaddle NC; Churchwell MI; Doerge DR
J AOAC Int; 2006; 89(4):1168-73. PubMed ID: 16915860
[TBL] [Abstract][Full Text] [Related]
17. Development of a high-performance liquid chromatography method with fluorescence detection for the routine quantification of tamoxifen, endoxifen and 4-hydroxytamoxifen in plasma from breast cancer patients.
Rangel-Méndez JA; Graniel-Sabido MJ; Sánchez-Cruz JF; Moo-Puc R
Biomed Chromatogr; 2019 Apr; 33(4):e4462. PubMed ID: 30536934
[TBL] [Abstract][Full Text] [Related]
18. Quantitative monitoring of tamoxifen in human plasma extended to 40 metabolites using liquid-chromatography high-resolution mass spectrometry: new investigation capabilities for clinical pharmacology.
Dahmane E; Boccard J; Csajka C; Rudaz S; Décosterd L; Genin E; Duretz B; Bromirski M; Zaman K; Testa B; Rochat B
Anal Bioanal Chem; 2014 Apr; 406(11):2627-40. PubMed ID: 24633563
[TBL] [Abstract][Full Text] [Related]
19. Solid-phase extraction and high-performance liquid chromatographic determination of tamoxifen and its major metabolites in plasma.
MacCallum J; Cummings J; Dixon JM; Miller WR
J Chromatogr B Biomed Appl; 1996 Apr; 678(2):317-23. PubMed ID: 8738037
[TBL] [Abstract][Full Text] [Related]
20. Direct determination of chlorpyrifos and its main metabolite 3,5, 6-trichloro-2-pyridinol in human serum and urine by coupled-column liquid chromatography/electrospray-tandem mass spectrometry.
Sancho JV; Pozo OJ; Hernández F
Rapid Commun Mass Spectrom; 2000; 14(16):1485-90. PubMed ID: 10931542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
